AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
October 09, 2024 09:00 ET
|
AIM ImmunoTech Inc.
OCALA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that Tom Equels, Chief Executive Officer of AIM, will participate in...
Entourage Health Provides Company Update
October 09, 2024 08:32 ET
|
Entourage Health Corp.
TORONTO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis...
SaverOne Expands European Reach in Spain and Portugal through a New Distribution Agreement with Sistemas ADAS
October 09, 2024 08:30 ET
|
SaverOne 2014 Ltd.
SaverOne accelerates its European expansion as part of its global growth strategy Petah Tikvah, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a...
Unit-Linked Insurance Market to Reach $2309.7 Billion, Globally, by 2032 at 10.9% CAGR: Allied Market Research
October 09, 2024 08:27 ET
|
Allied Analytics LLP
Wilmington, Delaware, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Unit-Linked Insurance Market by Mode (Online and Offline), and Distribution Channel...
Windtree Announces Publication of Positive Istaroxime Phase 2b Study Trial Design
October 09, 2024 08:00 ET
|
Windtree Therapeutics
WARRINGTON, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage...
Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials
October 09, 2024 08:00 ET
|
Evaxion Biotech
Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets Strongest outcomes are generated by the top-ranked...
At-home Testing Kits Market to be Worth USD 12.3 billion by 2034, Growing a CAGR 5.9% - Exclusive Report by Transparency Market Research, Inc.
October 09, 2024 07:20 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The global at-home testing kits market (재택 테스트 키트 시장) is estimated to ascend at a CAGR of...
FDA Grants Orphan Drug Designation to Can-Fite’s Namodenoson for Pancreatic Cancer
October 09, 2024 07:00 ET
|
Can-Fite BioPharma Ltd.
RAMAT GAN, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...
EXTR FRAUD NEWS: October 15 Class Action Deadline is Approaching; Extreme Networks, Inc. Investors that Lost Money are Notified to Contact BFA Law (Nasdaq:EXTR)
October 09, 2024 06:45 ET
|
Bleichmar Fonti & Auld
Extreme Networks, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 15, 2024 legal deadline.
Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
October 09, 2024 06:00 ET
|
Adagene Inc.
SAN DIEGO and SUZHOU, China, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today...